Call Us Today: 888-878-5295
CALL
TruLaw Logo
  • Home
  • Tru Lawsuits
      • 3T Heater Cooler
      • Abilify
      • Belviq & Belviq XR
      • Benicar
      • Breast Implants & Cancer
      • Diabetes Drugs & Skin Problems
      • Diacetyl
      • E-Cigarettes
      • Essure
      • Fluoroquinolone Antibiotics
      • Gadolinium
      • Invokana
      • Juul
      • IVC Filter
      • Levaquin, Cipro, Avelox
      • Mirena Brain Injury
      • Nexium, Prilosec, Prevacid (PPI)
      • Onglyza
      • Paragard Lawsuit
      • Paraquat
      • Personal Injury
      • Physiomesh / Hernia Mesh
      • Power Morcellator
      • Roundup & Cancer
      • Shoulder Replacement
      • Talcum Powder
      • Taxotere
      • Teething Products
      • Vaginal Rejuvenation
      • Valsartan
      • Xarelto
      • Zantac
      • Zostavax
    • Do I Have a Case?
      Receive instant real time feedback with our Instant Case Evaluator.
      Find Out Now
  • FDA
  • News
  • Instant Case Evaluation ℠
  • More +
Check My Case
  • Home
  • Why TruLaw?
  • Instant Case Evaluation ℠
    • All Case Evaluations
    • Abilify
    • Belviq & Belviq XR
    • Benicar
    • Diacetyl
    • Diabetes Drug / Skin Condition
    • Gadolinium
    • Heater Cooler
    • Invokana
    • Essure
    • Heartburn Drugs
    • IVC Filter
    • Juul
    • Mirena
    • Onglyza
    • Personal Injury
    • Physiomesh / Hernia Mesh
    • Roundup
    • Talcum Powder
    • Taxotere
    • Valsartan
    • Zantac Lawsuit
  • FDA
  • News
  • Lawsuit Information
    • Abilify
    • Belviq & Belviq XR
    • Benicar
    • Breast Implants & Cancer
    • Diacetyl Lawsuits
    • Diabetes Drugs & Skin Conditions
    • E-Cigarettes
    • Essure
    • Fluoroquinolone Antibiotics
    • Gadolinium
    • Heater Cooler
    • Invokana
    • IVC Filter
    • Juul
    • Mirena Brain Injury
    • Onglyza Lawsuit
    • Paragard Lawsuit
    • Paraquat
    • Physiomesh / Hernia Mesh
    • Power Morcellator
    • Proton Pump Inhibitor
    • Roundup
    • Shoulder Replacements
    • Talcum Powder
    • Taxotere
    • Teething Tablets and Gels
    • Vaginal Rejuvenation
    • Valsartan
    • Xarelto
    • Zantac Lawsuit
    • Zostavax
  • Featured Articles
  • Contact Us – Experienced Lawyers On Your Side
  • Legal Consultation
888-878-5295

FDA Warning & Recall Information

diocto-liquid-stool-softener-lawsuit-infant-deaths

After three recalls by the U.S. Food and Drug Administration (FDA) and the shuttering of its facility, Florida pharmaceutical company PharmaTech LLC is now the subject of seven stool softener lawsuits, several involving the death of an infant. Diocto Liquid PharmaTech LLC, the maker of […]

Jul 2, 2018 By Jessica Hoerman

Diocto Liquid, Subject of Stool Softener Lawsuit, Blamed for Infant Deaths 

FDA Warning Xeljanz linked to lung disease and pancreatic cancer

The U.S. Food and Drug Administration (FDA) approved Xeljanz and Xeljanz XR on November 6, 2012, and February 23, 2016, respectively. Both drugs are made by Pfizer, Inc. and were approved to treat moderate to severe active rheumatoid arthritis. Rheumatoid arthritis (RA) is the most […]

Nov 21, 2017 By Jessica Hoerman

FDA Warns – Xeljanz Label Updated To Include Serious Risks

FDA Warning Ocaliva LInked to Serious Liver Injury

The U.S. Food and Drug Administration (FDA) approved Ocaliva (obeticholic acid) on May 31, 2016, to treat primary biliary cholangitis (PBC), a chronic liver condition resulting from destruction of the bile ducts in the liver. When the bile ducts are impaired, bile builds up in […]

Nov 21, 2017 By Jessica Hoerman

FDA Warns Excessive Ocaliva Dosage Could Lead to Serious Liver Injury

FDA warning Trulicity linked to Anaphylactic Reactions

The U.S. Food and Drug Administration (FDA) approved Trulicity, a type 2 diabetes drug manufactured by Eli Lilly & Company, on September 18, 2014. The drug in combination with diet and exercise is intended to improve glycemic control in adults with type 2 diabetes mellitus. […]

Nov 21, 2017 By Jessica Hoerman

FDA Warns Trulicity May Lead to Anaphylactic Reactions, Anaphylaxis, and Angioedema

QVAR linked to Central Serous Chorioretinopathy

The U.S. Food and Drug Administration (FDA) approved Qvar (beclomethasone dipropionate hfa) on September 15, 2000, for the treatment of asthma. Qvar is a steroid manufactured by Teva Pharmaceutical Industries, Ltd. that works directly in the lungs to ease breathing by reducing the irritation and […]

Nov 21, 2017 By Jessica Hoerman

FDA Warns Qvar Use Could Lead to Blurred Vision, Central Serous Chorioretinopathy

FDA Warning Latuda is linked to Hyponatremia

The FDA warns that Latuda, a drug used to treat major depressive episodes, could lead to a serious condition called hyponatremia which occurs when water and sodium are out of balance in the body. Latuda is manufactured by Sunovion Pharmaceuticals Inc. The U.S. Food and Drug Administration (FDA) approved Latuda on October […]

Nov 21, 2017 By Jessica Hoerman

FDA Warns Latuda Use Could Lead to Hyponatremia

FDA Warning Marinol LInked to Serious Adverse Reactions

The U.S. Food and Drug Administration (FDA) approved Marinol (dronabinol) on May 31, 1985, for the treatment of anorexia nervosa associated with weight loss in patients with AIDS, and chemotherapy-induced nausea and vomiting (CINV). Marinol is manufactured by Unimed Pharmaceuticals, a subsidiary of Solvay Pharmaceuticals, and is usually prescribed […]

Nov 21, 2017 By Jessica Hoerman

FDA Warns Marinol Use May Lead to Number of Serious Adverse Effects 

FDA Warning Victozw linked to Acute Gallbladder Disease

Victoza is an injectable drug that was approved on January 25, 2010, to treat type 2 diabetes mellitus. Developed by Novo Nordisk, Victoza is similar to the natural hormone GLP-1 and helps maintain blood sugar, insulin levels, and digestion. Used with diet and exercise, the […]

Nov 21, 2017 By Jessica Hoerman

FDA Warns Victoza (liraglutide) Could Cause Acute Gallbladder Disease

FDA Warning Ofev linked to Drug-induced Liver Injury

The U.S. Food and Drug Administration (FDA) approved Ofev (nintedanib) capsules for the treatment of idiopathic pulmonary fibrosis (IPF) on October 15, 2014. IPF is a rare and fatal lung disease that affects as many as 132,000 patients in the U.S.  Pulmonary fibrosis is a […]

Nov 21, 2017 By Jessica Hoerman

FDA Warns – Ofev (nintedanib) May Cause Drug-Induced Liver Injury, Hyperbilirubinemia, And Jaundice

FDA Warning Epinephrine can lead to Stress Cardiomyopathy

Epinephrine was approved on May 23, 1984, to treat cardiac arrest and anaphylaxis. Endo International and GeoPharma, Inc manufacture the drug. Epinephrine, also known as adrenaline, is a hormone that is secreted by the adrenal glands. Adrenalin (without the e) was originally used as a […]

Nov 21, 2017 By Jessica Hoerman

FDA Warns Epinephrine Use Can Lead to Stress Cardiomyopathy

FDA Warning Carafate linked to Pulmonary & Cerebral Emboli

The FDA approved Carafate (sucralfate) in 1981 for the short-term treatment of active duodenal ulcers. A duodenal ulcer is a sore on the upper part of the small intestine and is very common with more than 200,000 cases in the U.S. every year. Carafate, an […]

Nov 21, 2017 By Jessica Hoerman

FDA Warns Carafate (sucralfate) May Cause Pulmonary & Cerebral Emboli

FDA Warning Statin Drugs Linked to Interstitial Lung Disease

Statin drugs lower the level of cholesterol in the blood by decreasing the production of cholesterol by the liver. Statins work by blocking hydroxy-methylglutaryl-coenzyme A reductase (HMG-CoA reductase), the enzyme in the liver that is responsible for producing cholesterol. Although cholesterol is essential to the […]

Nov 21, 2017 By Marty Chrenka

FDA Warns Cholesterol Lowering Statin Drugs Can Cause Interstitial Lung Disease

  • 1 (current)
  • 2
TruLaw Logo

TruLaw is a trusted resource for consumers to research the side effects of the drugs, medical devices and chemicals used by their family.  TruLaw works with experienced lawyers who are prepared to fight on behalf of individuals harmed by these same drugs, devices, chemicals and other products.  The Instant Case Evaluator ℠ provides consumers with an instant legal analysis free of charge. 

Quick Links
  • Why TruLaw
  • Contact Us – Experienced Lawyers On Your Side
  • Instant Case Evaluation ℠
  • Legal Consultation
  • News
  • Featured Articles
  • Infographics
Contact Us
  • 888-878-5295
  • info@trulaw.com
  • 210 S. Main St Suite 100
    Edwardsville, IL 62025

The contents of this website have been prepared by TruLaw, LLC located at 210 S Main St. Suite 100, Edwardsville IL 62025.   Jessica Paluch Hoerman is the attorney responsible for its content.  Jessica can be reached at 888-878-5295 or via email at Jess@TruLaw.com.  This website is considered “attorney advertising.” The choice of a lawyer is an important decision and should not be based solely upon advertisement. Sending or receiving information through this site, posting to our blogs/news site does not establish an attorney/client relationship. An attorney/client relationship with TruLaw, LLC is established only by an express and written agreement by TruLaw, LLC to represent you. Jessica Paluch Hoerman is licensed to practice in Illinois. In some circumstances, cases may be sent to other qualified lawyers. In those circumstances, TruLaw, LLC maintains joint responsibility.  TruLaw does not offer any guarantee of case results.  Past success in litigation does not guarantee success in any new or future lawsuits.

© 2021 Copyright TruLaw LLC - All rights reserved.